Eight Roads Ventures backed by Fidelity has revealed its first India-focused healthcare and life sciences fund of $250 million.
A portfolio of 25 companies has been collected by the funds in the healthcare and life sciences value chain since its first investment in the year 2011. The fresh funding raised is planned to focus on early- to growth-stage investments in the fields like- life sciences, healthcare services, consumer health, and digital health.
Around $8 billion of the capital of the fund’s network manages in $ countries like- China, India, Japan, Europe, and the US.
With a sum total of $1.6 billion worth of Assets Under Management (AUM), Eight Roads Ventures India has a portfolio of nearly 60 companies and invests in the broad sectors of healthcare and technology. The funding round has been participated by Pharmeasy parent API Holdings, Nicotex brand owner Cipla Health, plant-based nutrition brand OZiva, employee healthcare platform eKincare, and dental clear aligner brand Toothsi.
The fund’s healthcare-focused investment team in India has 15 members ranging from academics to professionals in the space. Eight Roads also revealed a technology-focused fund for China in March 2022, as part of its strategy to create sector-specific funds according to geographies.
EXECUTIVE OPINION:
“Eight Roads has backed innovative businesses in India since 2007. The launch of this healthcare fund reflects our confidence in the evolution of the Indian market and our commitment to helping ambitious founders scale,” said Daniel Auerbach, Senior Managing Partner and Head of Global Ventures at Eight Roads Ventures.
“Today is our first day one, as we deepen our commitment to the healthcare sector in India. We have had the privilege of partnering with some of the best healthcare entrepreneurs in the country to build category-defining businesses,” said Dr. Prem Pavoor, Senior Partner, Head of India, and Healthcare Investments at Eight Roads Ventures.
He further added, “Our aspiration is to continue backing such bold founders as India leapfrogs many other markets in delivering high-quality healthcare infrastructure, products, and services. We are grateful to our founders, partners, and the Fidelity ecosystem, for providing long-term and patient growth capital for our companies.”
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk
Posted By news desk